Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GSK – GlaxoSmithKline plc

GSK plc
GSK
$41.20
Name : GSK plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $83,494,682,624.00
EPSttm : 2.06
finviz dynamic chart for GSK
GSK plc
$41.20
0.12%
$0.05

Float Short %

0.83

Margin Of Safety %

18

Put/Call OI Ratio

0.63

EPS Next Q Diff

0.21

EPS Last/This Y

EPS This/Next Y

0.52

Price

41.19

Target Price

44.09

Analyst Recom

2.91

Performance Q

2.87

Relative Volume

0.59

Beta

0.52

Ticker: GSK




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08GSK36.860.530.99144011
2025-05-09GSK36.630.5412.23145209
2025-05-12GSK37.380.621.06147040
2025-05-13GSK36.360.630.25148592
2025-05-14GSK36.230.632.90148885
2025-05-15GSK37.610.640.10150194
2025-05-16GSK37.670.702.54142766
2025-05-19GSK37.960.570.32104735
2025-05-20GSK38.40.550.06108935
2025-05-21GSK38.540.550.15109051
2025-05-22GSK38.910.530.27113634
2025-05-23GSK38.690.521.62115420
2025-05-27GSK39.450.530.30113357
2025-05-28GSK39.20.533.36116420
2025-05-29GSK40.010.570.32121705
2025-05-30GSK41.030.580.95122799
2025-06-02GSK41.660.541.42115249
2025-06-03GSK40.470.561.23117764
2025-06-04GSK40.80.591.76124734
2025-06-05GSK41.150.601.76126308
2025-06-06GSK41.190.630.41134476
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08GSK36.873.35856.84.35
2025-05-09GSK36.623.36410.44.35
2025-05-12GSK37.373.36693.64.35
2025-05-13GSK36.353.35658.74.35
2025-05-14GSK36.233.36204.04.35
2025-05-15GSK37.603.36190.74.35
2025-05-16GSK37.673.36308.64.35
2025-05-19GSK37.963.35898.84.35
2025-05-20GSK38.403.36044.94.35
2025-05-21GSK38.533.35850.34.35
2025-05-22GSK38.903.36096.14.35
2025-05-23GSK38.683.35948.74.35
2025-05-27GSK39.443.36259.44.35
2025-05-28GSK39.203.35946.44.35
2025-05-29GSK40.023.36166.94.30
2025-05-30GSK41.033.36339.34.30
2025-06-02GSK41.663.36143.34.30
2025-06-03GSK40.463.35803.34.30
2025-06-04GSK40.803.36315.74.30
2025-06-05GSK41.153.36116.04.30
2025-06-06GSK41.193.36004.24.30
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08GSK0-3.970.81
2025-05-09GSK0-3.970.81
2025-05-12GSK0-3.870.86
2025-05-13GSK0-3.870.86
2025-05-14GSK0-3.870.86
2025-05-15GSK0-3.870.86
2025-05-16GSK0-3.870.86
2025-05-19GSK0-4.280.86
2025-05-20GSK0-4.280.86
2025-05-21GSK0-4.280.86
2025-05-22GSK0-4.280.86
2025-05-23GSK0-4.280.86
2025-05-27GSK0-4.500.86
2025-05-28GSK0-4.500.83
2025-05-29GSK0-4.500.83
2025-05-30GSK0-4.500.83
2025-06-02GSK0-4.500.83
2025-06-03GSK0-4.500.83
2025-06-04GSK0-4.500.83
2025-06-05GSK0-4.500.83
2025-06-06GSK0-4.500.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.13

Avg. EPS Est. Current Quarter

1.15

Avg. EPS Est. Next Quarter

1.34

Insider Transactions

Institutional Transactions

-4.5

Beta

0.52

Average Sales Estimate Current Quarter

7920

Average Sales Estimate Next Quarter

8230

Fair Value

48.43

Quality Score

87

Growth Score

71

Sentiment Score

77

Actual DrawDown %

14.7

Max Drawdown 5-Year %

-39.3

Target Price

44.09

P/E

21.39

Forward P/E

8.4

PEG

2.25

P/S

2.08

P/B

4.61

P/Free Cash Flow

13.18

EPS

1.93

Average EPS Est. Cur. Y​

4.3

EPS Next Y. (Est.)

4.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.89

Relative Volume

0.59

Return on Equity vs Sector %

-1.8

Return on Equity vs Industry %

-10

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

6004.2
GSK plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68629
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today
news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025
marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance
stock history GSK – GlaxoSmithKline plc invest stock market
stock prices GSK premarket after hours
ticker GSK fair value insiders trading